Skip to content

Clinical trials

Completed Atherosclerosis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Czechia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20091
20111
20122
20181
20201
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Amgen1
AstraZeneca1
CSL Behring1
Ionis Pharmaceuticals, Inc.1
Medtronic Endovascular1
NewAmsterdam Pharma1
Novartis Pharmaceuticals1
Sanofi1
Silence Therapeutics plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis13
Cardiovascular Diseases5
Coronary Disease3
Heart Diseases3
Acute Coronary Syndrome2
Coronary Artery Disease2
Peripheral Arterial Disease2
Stroke2
Atrial Fibrillation1
Dyslipidemias1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.